Ungstöd Sverige AB has been acquired by Nytida AB
Juni 2015 — Nytida AB has acquired Ungstöd Sverige AB for US$10 million.
Ungstöd, founded in 2007 and headquartered in Stockholm, is a non-institutional care provider offering services requiring state permits in accordance with the Social Services Act (sv. SoL) and the Act Concerning Support and Service for Persons with Certain Functional Impairments (sv. LSS). Ungstöd is a specialized care provider offering support and care for children with social and psychiatric problems.
Nytida AB is a leading player in the Swedish market offering support and assistance to people with medical and social disabilities. The company, with 250 established operations throughout the country and sales of approximately US$117 million, offers a wide range of non-institutional care services.
“Avantus has supported us throughout the whole process, with great commitment and sector expertise, and has played a pivotal role in what has become an outcome far beyond our expectations”, said Emil Wallgren, co-founder and CEO, Ungstöd.
Vår roll i transaktionen
Oaklins' team in Sweden advised the seller in this transaction.
Prata med transaktionsteamet
Relaterade transaktioner
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Lär dig merMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Lär dig merQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Lär dig mer